UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 362

Sortiert nach

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer

Nature (London), 2020-02, Vol.578 (7794), p.306-310

2020

Volltextzugriff (PDF)

Permitted daily exposure limits for noteworthy N‐nitrosamines

Environmental and molecular mutagenesis, 2021-06, Vol.62 (5), p.293-305

2021

Volltextzugriff (PDF)

Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines

Regulatory toxicology and pharmacology, 2022-11, Vol.135, p.105247-105247, Article 105247

2022

Volltextzugriff (PDF)

Exploring the molecular and functional cellular response to hydrazine via transcriptomics and DNA repair mutant cell lines

Environmental and molecular mutagenesis, 2022-08, Vol.63 (7), p.336-350

2022

Volltextzugriff (PDF)

A comparison of transgenic rodent mutation and in vivo comet assay responses for 91 chemicals

Mutation research. Genetic toxicology and environmental mutagenesis, 2019-03, Vol.839, p.21-35

2019

Volltextzugriff (PDF)

An Evaluation of the Occupational Health Hazards of Peptide Couplers

Chemical research in toxicology, 2022-06, Vol.35 (6), p.1011-1022

2022

Volltextzugriff (PDF)

Harmonized 3Rs-based non-mutagenic impurity qualification study designs developed using the results of an IQ consortium survey

Regulatory toxicology and pharmacology, 2021-06, Vol.122, p.104895, Article 104895

2021

Volltextzugriff (PDF)

A cross-industry survey on photosafety evaluation of pharmaceuticals after implementation of ICH S10

Regulatory toxicology and pharmacology, 2021-10, Vol.125, p.105017, Article 105017

2021

Volltextzugriff (PDF)

In vitro micronucleus screening of pharmaceutical candidates by flow cytometry in Chinese hamster V79 cells

Environmental and molecular mutagenesis, 2011-06, Vol.52 (5), p.355-362

2011

Volltextzugriff (PDF)

In vitro and in vivo mammalian mutation assays support a nonmutagenic mechanism of carcinogenicity for hydrazine

Environmental and molecular mutagenesis, 2021-01, Vol.62 (1), p.4-17

2021

Volltextzugriff (PDF)

A regenerative erythropoietic response does not increase the frequency of Pig‐a mutant reticulocytes and erythrocytes in Sprague‐Dawley rats

Environmental and molecular mutagenesis, 2018-01, Vol.59 (1), p.91-95

2018

Volltextzugriff (PDF)

Management of pharmaceutical ICH M7 (Q)SAR predictions – The impact of model updates

Regulatory toxicology and pharmacology, 2020-12, Vol.118, p.104807-104807, Article 104807

2020

Volltextzugriff (PDF)

Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses

Regulatory toxicology and pharmacology, 2016-06, Vol.77, p.13-24

2016

Volltextzugriff (PDF)

Utility of a next‐generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide

Environmental and molecular mutagenesis, 2021-11, Vol.62 (9), p.512-525

2021

Volltextzugriff (PDF)

Peptide bond‐forming reagents H OA t and H ATU are not mutagenic in the bacterial reverse mutation test

Environmental and molecular mutagenesis, 2016-04, Vol.57 (3), p.236-240

2016

Volltextzugriff (PDF)

Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities

Regulatory toxicology and pharmacology, 2013-10, Vol.67 (1), p.39-52

2013

Volltextzugriff (PDF)

Deriving Compound-Specific Exposure Limits for Chemicals Used in Pharmaceutical Synthesis: Challenges in Expert Decision-Making Exemplified Through a Case Study-Based Workshop

International journal of toxicology, 2021-05, Vol.40 (3), p.285-298

2021

Volltextzugriff (PDF)

Peptide bond-forming reagents HOAt and HATU are not mutagenic in the bacterial reverse mutation test

Environmental and molecular mutagenesis, 2016-04, Vol.57 (3), p.236-240

2016

Volltextzugriff (PDF)

Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present and future

Mutagenesis, 2011-01, Vol.26 (1), p.147-152

2011

Volltextzugriff (PDF)

Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses

Regulatory toxicology and pharmacology, 2019-03, Vol.102, p.53-64

2019

Volltextzugriff (PDF)

Chapter 7 - Genetic Toxicology Testing

A Comprehensive Guide to Toxicology in Nonclinical Drug Development, 2024, p.173-197

Nicolette, John

Third Edition, 2024

Volltextzugriff (PDF)

High content flow cytometric micronucleus scoring method is applicable to attachment cell lines

Environmental and molecular mutagenesis, 2010-04, Vol.51 (3), p.260-266

2010

Volltextzugriff (PDF)

Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present and future: MICRONUCLEI - Recent advances in their measurement in understanding of molecular mechanisms and their association with environment genetics and disease

Mutagenesis, 2011, Vol.26 (1), p.147-152

2011

Volltextzugriff (PDF)

Multi-lab validation of an improved flow cytometric in vitro micronucleus assay using attached cell lines

Toxicology letters, 2009-09, Vol.189, p.S84-S84

2009

Volltextzugriff (PDF)

1 – 25 von 362

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(332)
Mit Volltextzugriff
(328)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(229)
Life Sciences & Biomedicine
(210)
Humans
(142)
Female
(78)
Animals
(66)
Male
(64)
Biological And Medical Sciences
(53)
Adult
(47)
Middle Aged
(38)
Aged
(31)
Medical Sciences
(31)
Biochemistry & Molecular Biology
(29)
Rats
(29)
Fundamental And Applied Biological Sciences. Psychology
(28)
Environmental Sciences
(27)
Neurosciences & Neurology
(26)
Genetics & Heredity
(25)
Adolescent
(24)
Environmental Sciences & Ecology
(24)
Child
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer

Permitted daily exposure limits for noteworthy N‐nitrosamines

Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines

Exploring the molecular and functional cellular response to hydrazine via transcriptomics and DNA repair mutant cell lines

A comparison of transgenic rodent mutation and in vivo comet assay responses for 91 chemicals

An Evaluation of the Occupational Health Hazards of Peptide Couplers

Harmonized 3Rs-based non-mutagenic impurity qualification study designs developed using the results of an IQ consortium survey

A cross-industry survey on photosafety evaluation of pharmaceuticals after implementation of ICH S10

In vitro micronucleus screening of pharmaceutical candidates by flow cytometry in Chinese hamster V79 cells

In vitro and in vivo mammalian mutation assays support a nonmutagenic mechanism of carcinogenicity for hydrazine

A regenerative erythropoietic response does not increase the frequency of Pig‐a mutant reticulocytes and erythrocytes in Sprague‐Dawley rats

Management of pharmaceutical ICH M7 (Q)SAR predictions – The impact of model updates

Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses

Utility of a next‐generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide

Peptide bond‐forming reagents H OA t and H ATU are not mutagenic in the bacterial reverse mutation test

Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities

Deriving Compound-Specific Exposure Limits for Chemicals Used in Pharmaceutical Synthesis: Challenges in Expert Decision-Making Exemplified Through a Case Study-Based Workshop

Peptide bond-forming reagents HOAt and HATU are not mutagenic in the bacterial reverse mutation test

Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present and future

Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses

Chapter 7 - Genetic Toxicology Testing

International Pig-a gene mutation assay trial: Evaluation of transferability across 14 laboratories

High content flow cytometric micronucleus scoring method is applicable to attachment cell lines

Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present and future: MICRONUCLEI - Recent advances in their measurement in understanding of molecular mechanisms and their association with environment genetics and disease

Multi-lab validation of an improved flow cytometric in vitro micronucleus assay using attached cell lines

Suchergebnisse filtern